Open-label rusfertide
PTG-300-21
Phase 3 small_molecule active
Quick answer
Open-label rusfertide for Polycythemia Vera is a Phase 3 program (small_molecule) at Protagonist Therapeutics, Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protagonist Therapeutics, Inc
- Indication
- Polycythemia Vera
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active